Publications
91
Citations
993
Est. group size
~41
Recurring co-author estimate
Active years
34
Publishing since 1993
Typically publishes in teams of ~9 · 6% small-team papers (≤3 authors) · across 24 venues
- The discrete charm of oncolytic viruses: Toward the finish line
Cancer Cell · 2025
- A review of diffuse hemispheric glioma, H3 G34-mutant disease development, DNA repair, microenvironment, and treatments on the horizon
npj Precision Oncology · 2025
- Three-dimensional topological defects and quasi-long-range order in biological liquid crystals
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- FRI-123 The dose of radiation absorbed by the tumorand the non-tumoral compartments does not impact peripheral immune markers after SIRT
Journal of Hepatology · 2025
- Automated atomic site determination by four-dimensional scanning transmission electron microscopy data analytics
Ultramicroscopy · 2025
- Spatiotemporal Insights into Glioma Oncostream Dynamics: Unraveling Formation, Stability, and Disassembly Pathways
Advanced Science · 2024
- Cell and gene therapy in neuro-oncology
Handbook of clinical neurology · 2024
- Three recent breakthroughs in CAR T cells for the treatment of glioblastoma: Is it the light at the end of the tunnel?
Molecular Therapy · 2024
- TMIC-62. INVESTIGATING THE ROLE OF OSTEOPONTIN IN RADIORESISTANCE OF H3.3-G34R PEDIATRIC HIGH-GRADE GLIOMA
Neuro-Oncology · 2024
- Spatiotemporal Insights into Glioma Oncostream Dynamics: Unraveling Formation, Stability, and Disassembly Pathways (Adv. Sci. 18/2024)
Advanced Science · 2024
- Generation of 3D ex vivo mouse- and patient-derived glioma explant slice model for integration of confocal time-lapse imaging and spatial analysis
STAR Protocols · 2023
- Curcumin effects on Leydig cell functions and potential therapeutic uses
Endocrine Oncology · 2023
- Abstract 5835: Targeting discoidin domain receptor 1 (DDR1) reverses glioma immune suppression by remodeling collagen fiber architecture
Cancer Research · 2023
- CTIM-28. FIRST-IN-HUMAN TRANSGENE DETECTION 17 MONTHS POST-ADENOVIRAL THERAPY
Neuro-Oncology · 2023
- TMIC-03. TARGETING THE COLLAGEN RECEPTOR DDR1 PROMOTES ANTI-GLIOMA IMMUNITY BY REMODELING COLLAGEN FIBER ARCHITECTURE
Neuro-Oncology · 2023
- Neuro-Oncology×8
- bioRxiv (Cold Spring Harbor Laboratory)×6
- Frontiers in Oncology×2
- Advanced Science×2
- Cancer Research×2
- Stephen V. Carney
Medicine · University of Michigan
- Devarshi Mukherji
Medicine · University of Michigan
- Anzar Mujeeb
Medicine · University of Michigan
- Brandon Zhu
Medicine · University of Michigan
- Yayuan Liu
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile